Two-drug combination may slow deadly thyroid cancer

A combination of the drugs pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer (ATC), according to a new study. The two drugs together resulted in greater anti-cancer activity in ATC than either drug alone, according to new research.

Read the whole article on Science Daily

More from Science Daily